Verastem
(NASDAQ) VSTM
Verastem Financials at a Glance
Market Cap
$391.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$49.59M
Net Income (TTM)
-$193.96M
EPS (TTM)
-$2.74
P/E Ratio
-1.63
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Price
$4.87
Volume
2,448,417.822
Open
$4.49
Price
$4.87
Volume
2,448,417.822
Open
$4.49
Previous Close
$4.46
Daily Range
$4.30 - $4.99
52-Week Range
$3.43 - $11.25
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Price
$4.87
Volume
2,448,417.822
Open
$4.49
Previous Close
$4.46
Daily Range
$4.30 - $4.99
52-Week Range
$3.43 - $11.25
Estimated Earnings Date
Aug 6, 2026
VSTM News
Why Verastem Stock Sank Today
Top Drug Stocks Under $5
VSTM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Verastem
Industry
Biotechnology
Sector
Health CareEmployees
102
CEO
Dan Paterson
Website
www.verastem.comHeadquarters
Needham, MA 02494, US
VSTM Financials
Key Financial Metrics (TTM)
Gross Margin
83.75%
Operating Margin
-344.56%
Net Income Margin
-391.16%
Return on Equity
-486.41%
Return on Capital
-126.90%
Return on Assets
-85.14%
Earnings Yield
-61.35%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$391.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
87.87M
Volume
2.45M
Avg. Volume
2.46M
Financials (TTM)
Gross Profit
$41.53M
Operating Income
-$170.85M
EBITDA
-$191.95M
Operating Cash Flow
-$150.95M
Capital Expenditure
-$1.35M
Free Cash Flow
-$152.29M
Cash & ST Invst.
$181.68M
Total Debt
$85.48M
Verastem Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$18.67M
N/A
Gross Profit
$15.62M
N/A
Gross Margin
83.66%
N/A
Market Cap
$391.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$5.02M
N/A
Employees
78
N/A
Net Income
-$36.59M
+29.8%
EBITDA
-$35.93M
+30.8%
Quarterly Fundamentals
Total Cash
$181.68M
+54.5%
Total Debt
$85.48M
+11.3%
Accounts Receivable
$10.36M
+5079.0%
Inventory
$2.29M
N/A
Long Term Debt
$79.19M
+7.3%
Short Term Debt
$6.29M
+107.6%
Return on Assets
-85.14%
N/A
Return on Invested Capital
-1.06%
N/A
Free Cash Flow
-$52.12M
-34.8%
Operating Cash Flow
-$52.12M
-34.8%